Assistant clinical professor in the Division of Hematology/Oncology, School of Medicine at the University of California, Irvine.
Community Oncologists Show Comfort With Bispecifics in B-Cell Lymphoma
Elizabeth A. Brem, MD, discusses the shift she has seen in the community setting when it comes to using bispecific antibody therapy for patients with B-cell lymphoma.